Saxagliptin Tablet, Film Coated
Product Images NDC 68462-726

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Saxagliptin (NDC 68462-726). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2.5mg-label (2.5mg Label.jpg.jpg)

2.5mg-label (2.5mg Label.jpg.jpg)
Saxagliptin Tablets 2.5 mg film-coated oral tablets label from Glenmark Pharmaceuticals Inc., USA. The package contains 90 tablets. The label includes storage instructions, medication guidance availability, manufacturer details, an NDC number, and a barcode.*
FDA Label Image

5mg-label (5mg Label)

5mg-label (5mg Label)
Saxagliptin Tablets 5 mg film-coated tablets packaging label. The label indicates 90 tablets in the package, for oral use, and is distributed by Glenmark Pharmaceuticals Inc., USA. It includes dispensing instructions and storage information along with the NDC code 68462-727-90 and a barcode.*
FDA Label Image

Figure-1 (Image 01)

Figure-1 (Image 01)
A line graph showing mean percent change in A1C levels from baseline over 24 weeks for three groups: saxagliptin 2.5 mg plus metformin, saxagliptin 5 mg plus metformin, and placebo plus metformin. The y-axis displays A1C mean change, and the x-axis displays weeks. The plot includes error bars at week 24 LOCF for each group.*
FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
A Kaplan-Meier cumulative event probability chart showing event rates over days from randomization for Saxagliptin compared to Placebo. The chart plots event probabilities on the y-axis against days up to 1080 on the x-axis, with separate lines for Saxagliptin and Placebo treatment groups. A table below indicates the number at risk at various time points. A legend box summarizes event counts, percentages, and hazard ratio between groups.*
FDA Label Image

Saxagliptin Chemical Structure (Saxagliptin Struct)

Saxagliptin Chemical Structure (Saxagliptin Struct)
Chemical structure diagram of saxagliptin, showing its molecular framework including a bicyclic amide, amino and hydroxyl functional groups, a nitrile group, and a water molecule (H2O) indicating a hydrate form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.